Dopamine and angiotensin II (ATII) are also contraindicated in RVF, as dopamine risks arrhythmias and variable PVR effects, while ATII increases both PVR and SVR, potentially straining the RV [88] (Table 2). This evidence concerns the gene AGT and cardiac arrhythmia.